藥明康德(02359.HK)認購私募基金份額 涉資1500萬美元
格隆匯9月27日丨藥明康德(02359.HK)公吿,2021年9月27日,無錫藥明康德新藥開發股份有限公司(以下簡稱“公司”)全資子企業Wu Xi Pharma Tech Healthcare FundIL.P.(以下簡稱“WuXiFundI”)與LongwoodFundVIGP,LLC(以下簡稱“普通合夥人”)及Longwood Management,LLC(以下簡稱“管理公司”)簽署Amendedand Restated LimitedPartnershipAgreement(以下簡稱“合夥協議”),以及簽署Investor Questionnaire(以下簡稱“投資人問卷”),約定由WuXiFundI認繳Longwood FundVI,L.P.(以下簡稱“投資基金”)的1,500萬美元的投資基金份額(以下簡稱“本次投資”),約佔已募集投資基金份額的19.16%(WuXiFundI所持投資基金份額比例將隨投資基金後續從第三方投資機構及個人募資而進一步稀釋)。截至本公吿日,WuXiFundI尚未支付投資款,後續WuXiFundI將以自有資金根據合夥協議的要求履行投資款的支付義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.